Labiana Health Future Growth
Future criteria checks 5/6
Labiana Health is forecast to grow earnings and revenue by 98.9% and 10.1% per annum respectively. EPS is expected to grow by 97.6% per annum. Return on equity is forecast to be 37.8% in 3 years.
Key information
98.9%
Earnings growth rate
97.6%
EPS growth rate
| Pharmaceuticals earnings growth | 26.0% |
| Revenue growth rate | 10.1% |
| Future return on equity | 37.8% |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 84 | 4 | 3 | 12 | 2 |
| 12/31/2025 | 74 | 2 | 1 | 8 | 2 |
| 12/31/2024 | 66 | 1 | 4 | 6 | 2 |
| 6/30/2024 | 66 | -1 | -4 | -2 | N/A |
| 3/31/2024 | 63 | -3 | -4 | -2 | N/A |
| 12/31/2023 | 60 | -4 | -4 | -2 | N/A |
| 9/30/2023 | 60 | -7 | 0 | 4 | N/A |
| 6/30/2023 | 60 | -10 | 4 | 9 | N/A |
| 3/31/2023 | 60 | -9 | 2 | 7 | N/A |
| 12/31/2022 | 61 | -9 | -1 | 5 | N/A |
| 12/31/2021 | 59 | -2 | -1 | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LAB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: LAB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: LAB is expected to become profitable in the next 3 years.
Revenue vs Market: LAB's revenue (10.1% per year) is forecast to grow faster than the Spanish market (4.9% per year).
High Growth Revenue: LAB's revenue (10.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LAB's Return on Equity is forecast to be high in 3 years time (37.8%)